Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT05636033
Eligibility Criteria:
Inclusion Criteria:
For alcohol use disorder patients
* Severe alcohol use disorder
* French as mother tongue
* Right-hander
* Patient abstinent from alcohol since 15 to 30 days at the inclusion
* Patient free from benzodiazepine since at least 48hours at the inclusion
* Patient who gave his informed written consent
* Currently in outpatient or inpatient care
For healthy controls
* French as mother tongue
* Right-hander
* Participant who gave his informed written consent
Exclusion Criteria:
For alcohol use disorder patients
* Patient under guardianship or under justice safeguard measures
* Patient under measure of therapeutic injunction
* Pregnancy or breastfeeding declared
* Meeting Diagnostic and Statistical Manual 5 (DSM) criteria for substance use disorder other than Tobacco
* Meeting DSM-5 criteria for non substance use disorder
* Patient presenting severe or progressive disease that interfere with experimental tasks, such as neurological diseases (TBI, epilepsy, stoke) , hepatic diseases, cancer, HIV, Hepatitis C Virus (HCV), and unstable psychiatric comorbidities.
For healthy controls
* Participant under guardianship or under justice safeguard measures
* Participant under measure of therapeutic injunction
* Pregnancy or breastfeeding declared
* Meeting DSM-5 criteria for alcohol use disorder
* Meeting DSM-5 criteria for substance use disorder other than Tobacco
* Meeting DSM-5 criteria for non substance use disorder
* Currently under benzodiazepine
* Participant presenting severe or progressive disease that interfere with experimental tasks, such as neurological diseases (TBI, epilepsy, stoke) , hepatic diseases, cancer, HIV, HCV, and unstable psychiatric comorbidities.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
60 Years
Study:
NCT05636033
Study Brief:
Protocol Section:
NCT05636033